↓ Skip to main content

Escherichia coli Harboringmcr-1andblaCTX-Mon a Novel IncF Plasmid: First Report ofmcr-1in the United States

Overview of attention for article published in Antimicrobial Agents and Chemotherapy, May 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 13,569)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
245 news outlets
blogs
30 blogs
policy
1 policy source
twitter
261 tweeters
peer_reviews
1 peer review site
facebook
36 Facebook pages
googleplus
7 Google+ users
reddit
1 Redditor
video
1 video uploader

Citations

dimensions_citation
265 Dimensions

Readers on

mendeley
333 Mendeley
citeulike
2 CiteULike
Title
Escherichia coli Harboringmcr-1andblaCTX-Mon a Novel IncF Plasmid: First Report ofmcr-1in the United States
Published in
Antimicrobial Agents and Chemotherapy, May 2016
DOI 10.1128/aac.01103-16
Pubmed ID
Authors

Patrick McGann, Erik Snesrud, Rosslyn Maybank, Brendan Corey, Ana C. Ong, Robert Clifford, Mary Hinkle, Timothy Whitman, Emil Lesho, Kurt E. Schaecher

Abstract

The recent discovery of a plasmid-borne colistin resistance gene, mcr-1, heralds the emergence of truly pan-drug resistant bacteria (1).….

Twitter Demographics

The data shown below were collected from the profiles of 261 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 333 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 2%
Germany 2 <1%
India 2 <1%
Sweden 1 <1%
Brazil 1 <1%
Nepal 1 <1%
Thailand 1 <1%
Japan 1 <1%
Portugal 1 <1%
Other 0 0%
Unknown 318 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 69 21%
Student > Bachelor 50 15%
Researcher 50 15%
Student > Master 48 14%
Student > Doctoral Student 21 6%
Other 65 20%
Unknown 30 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 82 25%
Biochemistry, Genetics and Molecular Biology 50 15%
Medicine and Dentistry 42 13%
Immunology and Microbiology 41 12%
Chemistry 17 5%
Other 58 17%
Unknown 43 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 2310. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2018.
All research outputs
#1,567
of 17,063,122 outputs
Outputs from Antimicrobial Agents and Chemotherapy
#1
of 13,569 outputs
Outputs of similar age
#24
of 271,975 outputs
Outputs of similar age from Antimicrobial Agents and Chemotherapy
#1
of 260 outputs
Altmetric has tracked 17,063,122 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,569 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,975 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 260 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.